Clinical Trials Browser

Phase 2 × Adrenocortical Carcinoma × Bevacizumab × Clear all

NCT00469469 2015-04-22

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Phase 2 Withdrawn

Adrenocortical Carcinoma